Brief: Commodore Capital LP in SEC Filing Reports 19.7% Passive Stake In Vistagen Therapeutics As Of Aug 7
09/08/2023 23:16
Aug 9 (Reuters) - VistaGen Therapeutics Inc VTGN.O :
* COMMODORE CAPITAL LP REPORTS 19.7% PASSIVE STAKE IN
VISTAGEN
THERAPEUTICS AS OF AUGUST 7 - SEC FILING
Source text for Eikon: [http://bitly.ws/Rukb]
Further company coverage: VTGN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors